Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Best Pract Res Clin Haematol. 2012 Feb 5;25(1):75–89. doi: 10.1016/j.beha.2012.01.005

Table 2.

EBV-associated B-cell lymphomas in immunocompetent hosts

Lymphoma EBV frequency Latency Program
Burkitt’s lymphoma (endemic) 100% Type 1
Burkitt’s lymphoma (sporadic) 20–30% Type 1
Classical Hodgkin’s lymphoma 40% Type 2
DLBCL associated with chronic inflammation ~70% Type 2
EBV positive DLBCL of the elderly 100% Type 2
Lymphomatoid granulomatosis 100% Type 2